Skip to content

Drug interactions

Larotrectinib + Metaxalone

Severity: Minor

Larotrectinib and Metaxalone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor, so it may modestly raise metaxalone levels. The clinical effect is likely small, with a possible increase in sedation.

What this interaction means in plain words

Larotrectinib and Metaxalone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Larotrectinib belongs to Oncology; Metaxalone belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Larotrectinib inhibits CYP3A4, slightly reducing metaxalone clearance.

What to do

Monitor for increased drowsiness or dizziness and reduce the metaxalone dose if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Larotrectinib and Metaxalone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Larotrectinib with Metaxalone?

MediHelp rates the interaction as minor. Larotrectinib and Metaxalone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor, so it may modestly raise metaxalone levels. The clinical effect is likely small, with a possible increase in sedation.

How serious is the interaction between Larotrectinib and Metaxalone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for increased drowsiness or dizziness and reduce the metaxalone dose if needed.

What other medicines interact with Metaxalone?

MediHelp also lists interactions of Metaxalone with, for example, Alfentanil, Belladonna and opium, Benzhydrocodone / acetaminophen. The full list is on the Metaxalone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in